- ¥34bn
- ¥45bn
- ¥18bn
- 61
- 23
- 64
- 49
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 2.58 | ||
Price to Tang. Book | 2.76 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 1.8 | ||
EV to EBITDA | 19.87 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 4.68% | ||
Return on Equity | 6.35% | ||
Operating Margin | 5.86% |
Financial Summary
Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | ¥m | 10,593 | 12,906 | 15,693 | 18,351 | 17,740 | n/a | n/a | 10.89% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +34.46 | -10.16 | +70.82 | +26.76 | -46.79 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
I'rom Group Co.,Ltd. is engaged in medical fields such as regenerative medicine and gene discovery. The Company operates through four business segments. The SMO segment provides support services for contracting or substituting a part of the work related to conducting clinical trials from the conducting medical institution. The CRO segment provides all or part of clinical trial operations from pharmaceutical companies and others. The Advanced Medicinal Treatment segment is engaged in the development of gene therapy products, the development, manufacture and sale of products in the field of regenerative medicine based on iPS cells related technologies, as well as the provision of contract manufacture services. The Medical Support segment provides general and comprehensive support for medical business management, such as setting up and renting clinic malls, selling products and related services. The Company also provides business utilizing IT infrastructure.
Directors
- Toyotaka Mori PRE (56)
- Tsugumine Shu VPR
- Shuichi Kojima MEO (44)
- Toshiya Hara EDR (46)
- Hiroaki Inukai EDR (50)
- Chikaaki Kato EDR (56)
- Masayoshi Kikuoka EDR
- Hiroyuki Fukase OTH
- Masaaki Matsushima OTH (52)
- Yohei Tanida OTH (52)
- Tomoshi Oda DRC
- Hidetsugu Sasaki DRC
- Yusuke Sato DRC
- Yafeng Zhu DRC
- Toshikazu Kakudai IND (71)
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- April 9th, 1997
- Public Since
- October 1st, 2003
- No. of Shareholders
- 7,341
- No. of Employees
- 1,029
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Tokyo Stock Exchange
- Shares in Issue
- 12,105,253

- Address
- 5F/6F, CHIYODA-KU, 102-0071
- Web
- https://www.iromgroup.co.jp/
- Phone
- +81 332643148
- Auditors
- Avantia GP
Upcoming Events for 2372
Full Year 2025 I'rom Group Co Ltd Earnings Release
Similar to 2372
Advantage Risk Management Co
Tokyo Stock Exchange
AHC
Tokyo Stock Exchange
Amvis Holdings
Tokyo Stock Exchange
Artra
Tokyo Stock Exchange
As Partners Co
Tokyo Stock Exchange
FAQ
As of Today at 21:22 UTC, shares in I'rom Co are trading at ¥2,788. This share price information is delayed by 15 minutes.
Shares in I'rom Co last closed at ¥2,788 and the price had moved by +55.32% over the past 365 days. In terms of relative price strength the I'rom Co share price has outperformed the Nikkei 225 Index by +63.68% over the past year.
There is no consensus recommendation for this security.
Find out moreI'rom Co does not currently pay a dividend.
I'rom Co does not currently pay a dividend.
I'rom Co does not currently pay a dividend.
To buy shares in I'rom Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of ¥2,788, shares in I'rom Co had a market capitalisation of ¥34bn.
Here are the trading details for I'rom Co:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 2372
Based on an overall assessment of its quality, value and momentum I'rom Co is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like I'rom Co. Over the past six months, its share price has outperformed the Nikkei 225 Index by +8.67%.
As of the last closing price of ¥2,788, shares in I'rom Co were trading +1.29% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The I'rom Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at ¥2,788.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
I'rom Co's management team is headed by:
- Toyotaka Mori - PRE
- Tsugumine Shu - VPR
- Shuichi Kojima - MEO
- Toshiya Hara - EDR
- Hiroaki Inukai - EDR
- Chikaaki Kato - EDR
- Masayoshi Kikuoka - EDR
- Hiroyuki Fukase - OTH
- Masaaki Matsushima - OTH
- Yohei Tanida - OTH
- Tomoshi Oda - DRC
- Hidetsugu Sasaki - DRC
- Yusuke Sato - DRC
- Yafeng Zhu - DRC
- Toshikazu Kakudai - IND